Catalyst Wire Dossier Catalyst Wire Dossier

Imetelstat

imetelstat · Geron Corporation
Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for Imetelstat, covering 2012-11-21 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: Phase 2 Study Of Imetelstat for Patient With Myelodysplastic/Myeloproliferative Neoplasms [Phase 2]

See pricing